The new WHO guideline for control and elimination of human schistosomiasis:implications for the Schistosomiasis Elimination Programme in Nigeria  

作　　者：Akinola Stephen Oluwole Uwem Friday Ekpo Obiageli Josephine Nebe Nse Michael Akpan Solomon Monday Jacob Uche Veronica Amazigo John Russell Stothard 

机构地区：[1]Department of Pure and Applied Zoology,Federal University of Agriculture,Abeokuta,Ogun State,Nigeria [2]Neglected Tropical Disease Control Division,Department of Public Health,Federal Ministry of Health,Abuja,Nigeria [3]Pan-African Community Initiative on Education and Health(PACIEH),Enugu,Nigeria [4]Department of Tropical Disease Biology,Liverpool School of Tropical Medicine,Liverpool L35QA,UK.

出　　处：《Infectious Diseases of Poverty》2022年第5期87-89,共3页贫困所致传染病（英文）

摘　　要：Background With some 134,073,166 people living in endemic communities at risk of infection[1],Nigeria is the most endemic country in Africa and requires preventive chemotherapy(PC)for a total of 26.3 million persons[2].The National Schistosomiasis Elimination Programme(NSCHEP),with the support of international partners,has been implementing PC in Nigeria since 2009 and most recently will need to revise its current strategy(Additional file 1).For example,the new World Health Organization(WHO)guideline has six key recommendations that will dramatically change the implementation of schistosomiasis elimination in endemic countries[3].However,its impact and programmatic implications will vary from country to country,hence the need for a country-specific analysis.

关 键 词：SCHISTOSOMIASIS SCHISTOSOMIASIS NIGERIA 

分 类 号：R532.21[医药卫生—内科学]